Tue, February 3, 2009
[ Tue, Feb 03rd 2009 ] - Market Wire
Community Health Systems to Participate in the 2009 UBS Global Healthcare Services Conference
[ Tue, Feb 03rd 2009 ] - Market Wire
NexMed Announces Sale of U.S. Rights for Topical Erectile Dysfunction Treatment
[ Tue, Feb 03rd 2009 ] - Market Wire
Response Genetics Signs Agreement With Roche Diagnostics to Support Cancer Test Development
[ Tue, Feb 03rd 2009 ] - Market Wire
Affymax to Present at BIO CEO and Investor Conference
[ Tue, Feb 03rd 2009 ] - Market Wire
King Pharmaceuticals Announces Corporate Restructuring to Reduce Operating Expenses
[ Tue, Feb 03rd 2009 ] - Market Wire
PerkinElmer Expands LED Portfolio with Acquisition of Opto Technology, Inc.
[ Tue, Feb 03rd 2009 ] - Market Wire
Myriad Genetics: Myriad Genetics, Inc. Reports Results for Second Quarter of Fiscal 2009
[ Tue, Feb 03rd 2009 ] - Market Wire
Sequenom Announces Findings on Methylation Markers and RNA-SNP Markers as Presented at SMFM
[ Tue, Feb 03rd 2009 ] - Market Wire
Amarin to Present at the 11th Annual BIO CEO & Investor Conference
[ Tue, Feb 03rd 2009 ] - Market Wire
Reflect Scientific: $400,000 Order for Newly Rele .. 7000 System Received by Reflect Scientific, Inc.
[ Tue, Feb 03rd 2009 ] - Market Wire
Acorda Therapeutics to Present at the 11th Annual BIO CEO & Investor Conference
[ Tue, Feb 03rd 2009 ] - Market Wire
Amedisys Acquires Two Home Health Agencies in Arizona
[ Tue, Feb 03rd 2009 ] - Market Wire
GTx Announces Webcast of Corporate Presentation at the 11th Annual BIO CEO & Investor Conference
[ Tue, Feb 03rd 2009 ] - Market Wire
CeragenixAchieves 120 Daysof Antimicrobial Efficacy on Treated Silicone Medical Device.
[ Tue, Feb 03rd 2009 ] - Market Wire
Inspire Announces Webcast of Presentation at BIO CEO Conference
[ Tue, Feb 03rd 2009 ] - Market Wire
Compugen Announces Discovery of Biomarker Candida .. ian Cancer and Signing of Collaboration Agreement
[ Tue, Feb 03rd 2009 ] - Market Wire
Endologix to Hold 2008 Fourth Quarter and Full Ye .. Financial Results Conference Call on February 19
Mon, February 2, 2009
[ Mon, Feb 02nd 2009 ] - Market Wire
LHC Group and Ochsner Health System Complete Home Health Joint Venture
[ Mon, Feb 02nd 2009 ] - Market Wire
Corcept Therapeutics: CORLUX(R) Mitigates Weight .. al(R), Expands on Proof of Concept Established in
[ Mon, Feb 02nd 2009 ] - Market Wire
Medtronic Completes Enrollment in Global Head-to-Head Stent-Safety Study
[ Mon, Feb 02nd 2009 ] - Market Wire
Wright Medical Group, Inc. to Host Fourth Quarter 2008 Earnings Conference Call
[ Mon, Feb 02nd 2009 ] - Market Wire
Allos Therapeutics to Present at the 2009 BIO CEO & Investor Conference
[ Mon, Feb 02nd 2009 ] - Market Wire
Aetna Awarded $600,000 to Non-Profits in Maryland, Virginia and the District of Columbia
[ Mon, Feb 02nd 2009 ] - Market Wire
ZIOPHARM Oncology to Present at the 11th Annual BIO CEO & Investor Conference
[ Mon, Feb 02nd 2009 ] - Market Wire
Synta Completes Enrollment of the Phase 3 SYMMETR .. ial of Elesclomol in Stage IV Metastatic Melanoma
[ Mon, Feb 02nd 2009 ] - Market Wire
Community Health Systems, Inc. Announces the Acquisition of Siloam Springs, Arkansas Hospital
[ Mon, Feb 02nd 2009 ] - Market Wire
Auxilium Pharmaceuticals, Inc.: Auxilium Pharmace .. llment in Phase IIb Clinical Trial of XIAFLEX(TM)
[ Mon, Feb 02nd 2009 ] - Market Wire
Ceragenix and Hyphens Enter Into Distribution and Supply Agreement for EpiCeram®
[ Mon, Feb 02nd 2009 ] - Market Wire
Idera Pharmaceuticals Announces Achievement of Cl .. ollaboration with Merck KGaA for Cancer Treatment
[ Mon, Feb 02nd 2009 ] - Market Wire
Acorda Therapeutics Submits New Drug Application .. ment of Walking Ability in People with Multiple S
[ Mon, Feb 02nd 2009 ] - Market Wire
LifePoint Hospitals Acquires Rockdale Medical Center
[ Mon, Feb 02nd 2009 ] - Market Wire
SciClone Pharmaceuticals, Inc.: SciClone Pharmace .. icals to Present at BIO CEO & Investor Conference
[ Mon, Feb 02nd 2009 ] - Market Wire
Syneron Medical Ltd.: Syneron Medical Announces M .. Strengthening of Syneron's Leadership Position in
[ Mon, Feb 02nd 2009 ] - Market Wire
ZymoGenetics to Host Conference Call and Webcast .. , 2009 to Discuss 2008 Year-End Financial Results
Sun, February 1, 2009
[ Sun, Feb 01st 2009 ] - Market Wire
FORTIS: Fortis holding announcement
Sat, January 31, 2009
[ Sat, Jan 31st 2009 ] - Market Wire
FORTIS: Fortis holding publishes addendum to shareholder circular
[ Sat, Jan 31st 2009 ] - Market Wire
Resumen: REVLIMID® recibe recomendacin prelimina .. nal para la Salud y la Excelencia Clnica (NICE en
[ Sat, Jan 31st 2009 ] - Market Wire
REVLIMID® riceve indicazione preliminare positiv .. ealth and Clinical Excellence (NICE) per l'uso ne
[ Sat, Jan 31st 2009 ] - Market Wire
REVLIMID® erhlt die vorlufige Empfehlung des bri .. r Health and Clinical Excellence (NICE) zur Anwen
[ Sat, Jan 31st 2009 ] - Market Wire
REVLIMID® reoit un avis pr©alable favorable de .. et de l'excellence clinique (INEC) pour tre util
[ Sat, Jan 31st 2009 ] - Market Wire
REVLIMID® ontvangt positieve aanbeveling van het .. and Clinical Excellence (NICE) voor gebruik in d
Fri, January 30, 2009
[ Fri, Jan 30th 2009 ] - Market Wire
Biodel to Report First Quarter Fiscal Year 2009 R .. sults of Bioequivalence Study on February 5, 2009
[ Fri, Jan 30th 2009 ] - Market Wire
Teva Announces Approval of Generic Risperdal® Oral Solution
[ Fri, Jan 30th 2009 ] - Market Wire
Daxor Corp.: Daxor Announces Tahlequah City Hospi .. lequah, OK Acquires BVA-100 Blood Volume Analyzer
[ Fri, Jan 30th 2009 ] - Market Wire
First Patient Treated in Adipose Stem & Regenerative Cell Study for Stress Urinary Incontinence
[ Fri, Jan 30th 2009 ] - Market Wire
DexCom Announces Pricing of Public Offering of Common Stock
[ Fri, Jan 30th 2009 ] - Market Wire
Health Management Associates, Inc. to Present at .. lobal High Yield and Leveraged Finance Conference
[ Fri, Jan 30th 2009 ] - Market Wire
GeneThera: Dr. Antonio Milici of GeneThera Nomina .. for National Advisory Committee on Meat & Poultry
[ Fri, Jan 30th 2009 ] - Market Wire
CONMED Corporation: CONMED Corporation to Announc .. uarter 2008 Financial Results on February 5, 2009
[ Fri, Jan 30th 2009 ] - Market Wire
King Pharmaceuticals Announces Positive Results f .. ety and Efficacy Study of EMBEDA" Extended Releas
[ Fri, Jan 30th 2009 ] - Market Wire
Progen-Avexa Merger Update
[ Fri, Jan 30th 2009 ] - Market Wire
St. Jude Medical Announces 2009 Annual Investor Conference
[ Fri, Jan 30th 2009 ] - Market Wire
SonoSite Introduces Powerful New Turbo Technology for S Series"
[ Fri, Jan 30th 2009 ] - Market Wire
GTx Congratulates Dr. Duane D. Miller on His Indu .. Chemical Society Medicinal Chemistry Hall of Fame
[ Fri, Jan 30th 2009 ] - Market Wire
Hollis-Eden Pharmaceuticals to Present at 2009 BIO CEO and Investor Conference
[ Fri, Jan 30th 2009 ] - Market Wire
Forbes Names Illumina America?s Fastest-Growing Technology Company for Second Time
[ Fri, Jan 30th 2009 ] - Market Wire
REVLIMID® Receives Preliminary Positive Recommen .. for Health and Clinical Excellence (NICE) for Us
[ Fri, Jan 30th 2009 ] - Market Wire
Santarus Submits New Drug Application for ZEGERID Tablet Product
Thu, January 29, 2009
[ Thu, Jan 29th 2009 ] - Market Wire
EXACT Sciences Regains NASDAQ Compliance
[ Thu, Jan 29th 2009 ] - Market Wire
CompCare Acquires Core Corporate Consulting Group, Inc.
[ Thu, Jan 29th 2009 ] - Market Wire
Watson Pharmaceuticals: Watson to Host Fourth Qua .. ll Year 2008 Earnings Conference Call and Webcast
[ Thu, Jan 29th 2009 ] - Market Wire
Seattle Genetics to Host Conference Call and Webc .. ter and Year 2008 Financial Results on February 5
[ Thu, Jan 29th 2009 ] - Market Wire
Aetna Awarded $125,000 to North Carolina Non-Profits
[ Thu, Jan 29th 2009 ] - Market Wire
Aetna Awarded $857,500 to Non-Profits in Florida
[ Thu, Jan 29th 2009 ] - Market Wire
Bio-Imaging Technologies to Present at the UBS Gl .. erence on February 9, 2009 at the Waldorf Astoria
[ Thu, Jan 29th 2009 ] - Market Wire
Eurand N.V.: FDA Accepts Eurand's Response to Approvable Letter for EUR-1008 as Complete
[ Thu, Jan 29th 2009 ] - Market Wire
Synta Pharmaceuticals to Present at the BIO CEO & Investor Conference 2009
[ Thu, Jan 29th 2009 ] - Market Wire
Humana and Wisconsin Health Information Exchange Announce Collaborative Business Program
[ Thu, Jan 29th 2009 ] - Market Wire
ARIAD to Webcast Conference Call on Fourth Quarter and Year-End 2008 Financial Results
[ Thu, Jan 29th 2009 ] - Market Wire
University of Texas at Austin Acquires SOLiD System to Advance Genomic Research
[ Thu, Jan 29th 2009 ] - Market Wire
Alexion?s Soliris(R) (eculizumab) Receives Marketing Approval in Canada for All Patients with PNH
[ Thu, Jan 29th 2009 ] - Market Wire
Spectranetics Announces Executive Appointments to Further Enhance Compliance Programs
[ Thu, Jan 29th 2009 ] - Market Wire
Transcend Reports 18% Revenue Growth, 28% Increas .. in Pre-Tax Income and Earnings Per Share of $.17
[ Thu, Jan 29th 2009 ] - Market Wire
POZEN Informed by FDA That Endoscopic Gastric Ulc .. ce Continues to Be an Acceptable Primary Endpoint
[ Thu, Jan 29th 2009 ] - Market Wire
Micrus Endovascular to Hold Fiscal 2009 Third Quarter Conference Call on February 5
Wed, January 28, 2009
[ Wed, Jan 28th 2009 ] - Market Wire
Enzon Nominates Two New Candidates for Its Board of Directors
[ Wed, Jan 28th 2009 ] - Market Wire
Aetna Announces 2009 Annual Meeting Details
[ Wed, Jan 28th 2009 ] - Market Wire
CombinatoRx Publishes Data on Selective Amplification of Synergistic Combination Drug Candidate
[ Wed, Jan 28th 2009 ] - Market Wire
Positron Corporation?s Joint Venture Submits FDA 510(k) for its Attrius" PET Scanner
[ Wed, Jan 28th 2009 ] - Market Wire
Hansen Medical, Inc.: Hansen Medical Announces 2008 Fourth Quarter Conference Call
[ Wed, Jan 28th 2009 ] - Market Wire
Vitro Receives Notice of Allowance for Adult Stem .. rom the United States Patent and Trademark Office
[ Wed, Jan 28th 2009 ] - Market Wire
Resumen: Gilead esboza las prioridades de I+D para 2009
[ Wed, Jan 28th 2009 ] - Market Wire
Samenvatting: Gilead zet prioriteiten O&O uiteen voor 2009
[ Wed, Jan 28th 2009 ] - Market Wire
Gilead gibt Schwerpunkte fr Forschung und Entwicklung 2009 bekannt
[ Wed, Jan 28th 2009 ] - Market Wire
Synovis Life Technologies to Webcast Fiscal First .. r Earnings Conference Call Wednesday, February 25
[ Wed, Jan 28th 2009 ] - Market Wire
VIVUS Announces Senior Management Promotions
[ Wed, Jan 28th 2009 ] - Market Wire
Geron Announces John Walker Resigns as Director
[ Wed, Jan 28th 2009 ] - Market Wire
Sequenom Terminates Exchange Offer to Acquire EXACT Sciences
[ Wed, Jan 28th 2009 ] - Market Wire
Medtronic Expands CURE-AF Clinical Program into Europe and Canada
[ Wed, Jan 28th 2009 ] - Market Wire
ImmunoGen, Inc. Announces Webcast of its Investment Community Meeting on February 27, 2009
[ Wed, Jan 28th 2009 ] - Market Wire
U.S. FDA Approves OraQuick ADVANCE® 12-Month Shelf Life Dating
[ Wed, Jan 28th 2009 ] - Market Wire
ZymoGenetics Secures Worldwide Rights to IL-21
Tue, January 27, 2009
[ Tue, Jan 27th 2009 ] - Market Wire
Allana Resources Inc.: Allana Resources Inc. Prov .. ication on Engagement of Investor Relations Group
[ Tue, Jan 27th 2009 ] - Market Wire
UnitedHealth Group/PacifiCare Awards More Than $5 .. Grants to Help Improve Health Care in California
[ Tue, Jan 27th 2009 ] - Market Wire
Cavit Sciences, Inc.: Cavit Sciences Announces Update to Shareholders
[ Tue, Jan 27th 2009 ] - Market Wire
UnitedHealth Group?s Evercare Business Awarded for Innovation in Coordinated Care
[ Tue, Jan 27th 2009 ] - Market Wire
Allana Resources Inc.: Allana Resources Inc. Engages Investor Relations Group
[ Tue, Jan 27th 2009 ] - Market Wire
Astellas Proposes to Acquire CV Therapeutics for $16 Per Share in Cash
[ Tue, Jan 27th 2009 ] - Market Wire
Oculus Innovative Sciences Announces $3 Million I .. tner to Fund Oculus to Profitability in 12 Months
[ Tue, Jan 27th 2009 ] - Market Wire
DOR BioPharma, Inc.: DOR BioPharma Announces Appo .. pher J. Schaber, PhD, to BioNJ Board of Directors
[ Tue, Jan 27th 2009 ] - Market Wire
Alnylam Promotes Akshay Vaishnaw to Senior Vice President, Clinical Research
[ Tue, Jan 27th 2009 ] - Market Wire
St. Jude Medical Reports Fourth Quarter and Full-Year 2008 Results
[ Tue, Jan 27th 2009 ] - Market Wire
Reflect Scientific: Reflect Scientific Adds Midwest Sales Representative
[ Tue, Jan 27th 2009 ] - Market Wire
Sequenom Commences Exchange Offer to Acquire EXACT Sciences
[ Tue, Jan 27th 2009 ] - Market Wire
PhotoMedex Announces Effectiveness of 1-for-7 Reverse Stock Split
[ Tue, Jan 27th 2009 ] - Market Wire
Inspire Initiates Phase 3 Prolacria" Dry Eye Trial under Special Protocol Assessment Agreement
[ Tue, Jan 27th 2009 ] - Market Wire
Illumina Launches Suite of Next-Generation Sequencing Kits
[ Tue, Jan 27th 2009 ] - Market Wire
Zacks Bull & Bear of the Day Highlights: Onyx Pha .. wfield Exploration, D.R. Horton, KB Home and MGIC
[ Tue, Jan 27th 2009 ] - Market Wire
SCOR: SCOR sets up Zurich Hub
Mon, January 26, 2009
[ Mon, Jan 26th 2009 ] - Market Wire
Oculus Innovative Sciences Reduces Additional Cas .. ion as Company Targets Breakeven Within 12 Months
[ Mon, Jan 26th 2009 ] - jason scholder
First Stem Cell Study For Spinal Injury Approved. New Hope For Back Pain Sufferers Worldwide.
[ Mon, Jan 26th 2009 ] - Market Wire
Theravance, Inc.: Theravance Submits U.S. NDA for .. for the Treatment of Hospital-Acquired Pneumonia
[ Mon, Jan 26th 2009 ] - Market Wire
HealthSpring to Webcast Its Investor Day on February 27, 2009
[ Mon, Jan 26th 2009 ] - Market Wire
PhotoMedex Announces Results of Stockholders? Meeting
[ Mon, Jan 26th 2009 ] - Market Wire
DelSite, Inc.: DelSite, Inc. Discontinues Manufac .. DA Approval to Initiate Phase I Clinical Study fo
[ Mon, Jan 26th 2009 ] - Market Wire
Mannatech Launches Economic Stimulus Plan for Business Builders
[ Mon, Jan 26th 2009 ] - Market Wire
Seattle Genetics Receives Orphan Drug Designations for SGN-35 in the United States and Europe
[ Mon, Jan 26th 2009 ] - Market Wire
DOR BioPharma, Inc.: DOR BioPharma Announces Form .. Acute Radiation Enteritis Medical Advisory Board
[ Mon, Jan 26th 2009 ] - Market Wire
Endurance Athletes Get High-Quality Results with Low-Cal Accelerade Hydro and Endurox Restore
[ Mon, Jan 26th 2009 ] - Market Wire
St. Jude Medical Announces European CE Mark Appro .. Brain Stimulation Systems for Parkinson?s Disease
[ Mon, Jan 26th 2009 ] - Market Wire
Collaboration Between RXi Pharmaceuticals and the .. Medical School Receives a Massachusetts Life Scie
[ Mon, Jan 26th 2009 ] - Market Wire
MEDNAX 2008 Fourth Quarter Conference Call/Webcast Scheduled for February 5, 2009
[ Mon, Jan 26th 2009 ] - Market Wire
Sequenom Names Allan T. Bombard, M.D., Chief Medical Officer
[ Mon, Jan 26th 2009 ] - Market Wire
MEDIA ADVISORY: Pfizer and Wyeth to Host Live Press Conference in New York
[ Mon, Jan 26th 2009 ] - Market Wire
Pfizer to Acquire Wyeth, Creating the World's Premier Biopharmaceutical Company
[ Mon, Jan 26th 2009 ] - Market Wire
WellCare Files 2007 Annual Report on Form 10-K
[ Mon, Jan 26th 2009 ] - Market Wire
Zacks Bull & Bear of the Day Highlights: WellPoin .. tech, Green Mountain Coffee, Peet's and Starbucks
Sun, January 25, 2009
[ Sun, Jan 25th 2009 ] - Market Wire
Crucell N.V.: Discussions on a Combination of Crucell and Wyeth Discontinued
[ Sun, Jan 25th 2009 ] - Marc Woodard
Heal Back Pain Without Surgery - Embryonic Stem Cell Update!
Fri, January 23, 2009
[ Fri, Jan 23rd 2009 ] - Market Wire
Alcon Placed for the 11th Consecutive Year on FOR .. agazine?s List of 100 Best Companies to Work For?
[ Fri, Jan 23rd 2009 ] - Market Wire
Advanced Viral Research Corp.: Advanced Viral Ann .. f Operations Due to Inability to Secure Financing
[ Fri, Jan 23rd 2009 ] - Market Wire
Urologix to Host Its Fiscal 2009 Second Quarter Conference Call
[ Fri, Jan 23rd 2009 ] - Market Wire
NeoPharm, Inc. Announces Voluntary Delisting from NASDAQ and Deregistration of Common Stock
[ Fri, Jan 23rd 2009 ] - Market Wire
Sepracor Inc. Sets Conference Call and Webcast fo .. urth Quarter and Full-Year 2008 Operating Results
[ Fri, Jan 23rd 2009 ] - Market Wire
ImClone Systems and Bristol-Myers Squibb Update t .. ung Cancer Supplemental Biologics Application Sub
[ Fri, Jan 23rd 2009 ] - Market Wire
CLX Medical, Inc.: CLX Medical, Inc. Issues CEO C .. ith Ownership and Planned Distribution of FDA Cle
[ Fri, Jan 23rd 2009 ] - Market Wire
International Stem Cell Receives Second $1M Tranche Under $5 Million Financing
[ Fri, Jan 23rd 2009 ] - Market Wire
Alnylam Receives Clearance from FDA to Initiate P .. y with ALN-VSP for the Treatment of Liver Cancers
[ Fri, Jan 23rd 2009 ] - Market Wire
Hollis-Eden Researchers Present New Findings on M .. ancer Drug Candidate APOPTONE" (HE3235) at Americ
[ Fri, Jan 23rd 2009 ] - Market Wire
GTx Announces Conference Call to Discuss EMEA Label Changes to Fareston®
[ Fri, Jan 23rd 2009 ] - Market Wire
Centene Corporation?s Georgia Subsidiary Receives Prestigious NCQA Accreditation
[ Fri, Jan 23rd 2009 ] - Market Wire
Zacks Bull and Bear of the Day Highlights: Abbott Labs, Hubbell, Wipro, Citigroup and Infosys
Thu, January 22, 2009
[ Thu, Jan 22nd 2009 ] - Market Wire
Life Technologies Sets 4th Quarter and Full Year .. ings Release Date for Thursday, February 12, 2009
[ Thu, Jan 22nd 2009 ] - Market Wire
Cubist Pharmaceuticals Reports GAAP Diluted Net I .. ourth Quarter 2008 and GAAP Diluted Net Income of
[ Thu, Jan 22nd 2009 ] - Market Wire
OPKO Health Initiates Clinical Trial of the Aquashunt" to Treat Glaucoma
[ Thu, Jan 22nd 2009 ] - Market Wire
Proton Laboratories Inc.: Transparency - Sales - .. ton Laboratories Building on Years of Development
[ Thu, Jan 22nd 2009 ] - Market Wire
Bard to Host Earnings Conference Call on January 29, 2009
[ Thu, Jan 22nd 2009 ] - Market Wire
LifeVantage Names Network Marketing Expert Randal Wojta as Master Distributor for the Company
[ Thu, Jan 22nd 2009 ] - Market Wire
Simon Stevens Appointed Executive Vice President .. terprise-Wide Health Care Reform Engagement; Will
[ Thu, Jan 22nd 2009 ] - Market Wire
RXi Pharmaceuticals Appoints Rudolph Nisi, M.D. to Board of Directors
[ Thu, Jan 22nd 2009 ] - Market Wire
Antares Pharma Receives Milestone Payment from Teva for Pen Injector Device Filing
[ Thu, Jan 22nd 2009 ] - Market Wire
ZOLL Receives Clearance to Market New R Series BLS and R Series Plus Defibrillators
[ Thu, Jan 22nd 2009 ] - Market Wire
Ottawa Paramedic Service Awards ZOLL a Third Contract as Preferred Vendor for Defibrillators
[ Thu, Jan 22nd 2009 ] - Market Wire
OR-Live, Inc.: REMINDER: Surgical Tutorial on da Vinci(R) Anterior Pelvic Exenteration
[ Thu, Jan 22nd 2009 ] - Market Wire
Reflect Scientific: Reflect Scientific, Inc. Rece .. Design Contract for Controlled Environment System
[ Thu, Jan 22nd 2009 ] - Market Wire
Tenet Announces Preliminary Results for Fourth Quarter and Full Year 2008
[ Thu, Jan 22nd 2009 ] - Market Wire
Tenet Announces Exchange Offer for up to $1.6 Bil .. egate Principal Amount of Notes Due 2011 and 2012
[ Thu, Jan 22nd 2009 ] - Market Wire
ImmunoGen, Inc. Announces Conference Call to Disc .. Second Quarter Fiscal Year 2009 Financial Results
[ Thu, Jan 22nd 2009 ] - Market Wire
BioDelivery Sciences Files Shelf Registration
Wed, January 21, 2009
[ Wed, Jan 21st 2009 ] - Market Wire
Sernova Corp.: Sernova Corp.: Resignation of Just .. dent Board of Directors Initiates Internal Review
[ Wed, Jan 21st 2009 ] - Market Wire
Iris BioTechnologies Launches Health Passport in .. ics System for Personalized and Targeted Medicine
[ Wed, Jan 21st 2009 ] - Market Wire
Reed Tuckson, M.D., Named One of Black Enterprise .. ves in Corporate America and Featured on February
[ Wed, Jan 21st 2009 ] - Market Wire
ReGen Biologics Announces Common Stock Financing .. ort Launch of Menaflex" Collagen Meniscus Implant
[ Wed, Jan 21st 2009 ] - Market Wire
Lifeline Biotechnologies, Inc. Announces Corporat .. for the Commencement of Commercialization Strate
[ Wed, Jan 21st 2009 ] - Market Wire
Abiomed to Showcase Impella® Heart Recovery Platform at STS 2009
[ Wed, Jan 21st 2009 ] - Market Wire
Nanogen Announces Changes in Merger Plans
[ Wed, Jan 21st 2009 ] - Market Wire
Abraxis BioScience Names Merck Veteran Van der Pl .. &D and Drug Development Efforts at Abraxis Health
[ Wed, Jan 21st 2009 ] - Market Wire
Myriad Pharmaceuticals, Inc.: Myriad Pharmaceuticals Acquires Novel HIV Drug, Bevirimat
[ Wed, Jan 21st 2009 ] - Market Wire
Celgene Corporation to Announce Fourth Quarter and Full-Year 2008 Results on January 29, 2009
[ Wed, Jan 21st 2009 ] - Market Wire
Jan Keltjens Appointed President & CEO of AngioDynamics
[ Wed, Jan 21st 2009 ] - Market Wire
Medical Action Industries 3rd Quarter Earnings Call to Take Place on February 4, 2009
[ Wed, Jan 21st 2009 ] - Market Wire
King Pharmaceuticals Reports Intent to Appeal SKELAXIN® Summary Judgment Order
[ Wed, Jan 21st 2009 ] - Market Wire
Aradigm Reports Positive Phase 2 Results with Inh .. cin Hydrochloride in Patients with Bronchiectasis
[ Wed, Jan 21st 2009 ] - Market Wire
Panacos Announces Sale of Bevirimat
[ Wed, Jan 21st 2009 ] - Market Wire
Spectranetics Reports on 12-Month CELLO Data at LINC Meeting in Leipzig, Germany
[ Wed, Jan 21st 2009 ] - Market Wire
Zacks Bull & Bear of the Day Highlights: AMAG Pha .. s, Logitech, Regions Financial and PetMed Express
Tue, January 20, 2009
[ Tue, Jan 20th 2009 ] - Market Wire
AVI BioPharma, Inc.: AVI BioPharma Announces Conf .. 1, 2009 to Provide Update on Duchenne Muscular Dy
[ Tue, Jan 20th 2009 ] - Market Wire
Opexa Provides Update on Various Corporate Developments
[ Tue, Jan 20th 2009 ] - Market Wire
CORRECTING and REPLACING CytoCore and Zycom to Sign Distribution Agreement
[ Tue, Jan 20th 2009 ] - Market Wire
Vein Clinics of America Opens New Location in Cincinnati
[ Tue, Jan 20th 2009 ] - Market Wire
NovaBay Pharmaceuticals, Inc.: NovaBay (NBY) Appo .. D, Former Amgen President/Chief Operating Officer
[ Tue, Jan 20th 2009 ] - Market Wire
Clinical Data?s Cogenics Division Partners with S .. igh Quality Clinical Genotyping Services in China
[ Tue, Jan 20th 2009 ] - Market Wire
Metabasis Therapeutics Announces Corporate Restructuring and Workforce Reduction
[ Tue, Jan 20th 2009 ] - Market Wire
Abraxis BioScience Announces Plan to Create Abrax .. e Focused on Biomarkers and Personalized Medicine
[ Tue, Jan 20th 2009 ] - Market Wire
PetMed Express, Inc. D/B/A 1-800-PetMeds Announces Third Quarter Financial Results
[ Tue, Jan 20th 2009 ] - Market Wire
Luminex Corporation Announces Organizational Change
[ Tue, Jan 20th 2009 ] - Market Wire
Celldex Announces License of its Cholera and ETEC Vaccine Programs
[ Tue, Jan 20th 2009 ] - Market Wire
Invacare Corporation to Host Conference Call to Discuss Q4 2008 Results
[ Tue, Jan 20th 2009 ] - Market Wire
Quidel Corporation Appoints Douglas C. Bryant President & Chief Executive Officer
[ Tue, Jan 20th 2009 ] - Market Wire
Dr. Reddy?s Q3 FY09 Revenue at Rs. 18,401 million .. DA at Rs. 3,453 million, PAT at Rs. 1,924 million
[ Tue, Jan 20th 2009 ] - Market Wire
Natus Medical Announces Preliminary 2008 Fourth Q .. and Full Year Results and Provides 2009 Guidance
[ Tue, Jan 20th 2009 ] - Market Wire
CytoCore and Zycom to Sign Distribution Agreement
[ Tue, Jan 20th 2009 ] - Market Wire
Illumina to Announce Fourth Quarter and Fiscal Ye .. 08 Financial Results on Tuesday, February 3, 2009
Mon, January 19, 2009
[ Mon, Jan 19th 2009 ] - Market Wire
Teva and Lonza Announce Strategic Partnership to Become a Leading Global Provider of Biosimilars
[ Mon, Jan 19th 2009 ] - Market Wire
Given Imaging: Given Imaging Announces Expansion of Distribution Relationship With FUJIFILM
[ Mon, Jan 19th 2009 ] - Market Wire
FDA Grants Orphan Drug Designation to ChemGenex?s .. ne for the Treatment of Myelodysplastic Syndromes
[ Mon, Jan 19th 2009 ] - Market Wire
UnitedHealth Group Wins Summary Judgment on All Claims in Omnicare Litigation
[ Mon, Jan 19th 2009 ] - Market Wire
Chemed to Report Fourth-Quarter 2008 Earnings Feb .. 6, Related Conference Call to Be Held February 17
[ Mon, Jan 19th 2009 ] - Market Wire
Transcend Services Announces Date for Fourth Quarter 2008 Earnings Release and Conference Call
[ Mon, Jan 19th 2009 ] - Market Wire
SCOR: SCOR Wins Risk Magazine's 'Insurance Risk Manager of the Year' Award

Riassunto: Gilead Science comunica i risultati finanziari da record registrati nel quarto trimestre e durante l?intero esercizi


//health-fitness.news-articles.net/content/2009/ .. uarto-trimestre-e-durante-l-intero-esercizi.html
Published in Health and Fitness on Tuesday, January 27th 2009 at 15:34 GMT, Last Modified on 2009-01-27 15:35:15 by Market Wire   Print publication without navigation


FOSTER CITY, California--([ BUSINESS WIRE ])--Gilead Sciences, Inc. (Nasdaq : GILD) ha comunicato oggi i risultati d'esercizio registrati nel quarto trimestre e durante l'intero esercizio 2008. I ricavi totali per il quarto trimestre del 2008 ammontano a 1,43 miliardi di dollari, il che corrisponde a un aumento del 30 percento rispetto ai ricavi totali di 1,09 miliardi di dollari registrati nel quarto trimestre del 2007.

Il testo originale del presente annuncio, redatto nella lingua di partenza, è la versione ufficiale che fa fede. Le traduzioni sono offerte unicamente per comodità del lettore e devono rinviare al testo in lingua originale, che è l'unico giuridicamente valido.


Publication Contributing Sources

Similar Health and Fitness Publications
[ Mon, Jan 12th 2009 ] - Market Wire
[ Mon, Jan 12th 2009 ] - Market Wire
[ Tue, Dec 23rd 2008 ] - Market Wire
[ Mon, Dec 22nd 2008 ] - Market Wire
[ Mon, Dec 22nd 2008 ] - Market Wire
[ Thu, Dec 18th 2008 ] - Market Wire
[ Wed, Dec 17th 2008 ] - Market Wire
[ Wed, Dec 10th 2008 ] - Market Wire
[ Tue, Dec 09th 2008 ] - Market Wire
[ Mon, Dec 08th 2008 ] - Market Wire
[ Fri, Dec 05th 2008 ] - Market Wire
[ Thu, Nov 27th 2008 ] - Market Wire